Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Takaharu Ichimura, Ph.D.

Co-Author

This page shows the publications co-authored by Takaharu Ichimura and Vivek Kasinath.
Connection Strength

0.631
  1. Urine podoplanin heralds the onset of ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol. 2019 05 01; 316(5):F957-F965.
    View in: PubMed
    Score: 0.201
  2. ACTH treatment promotes murine cardiac allograft acceptance. JCI Insight. 2021 07 08; 6(13).
    View in: PubMed
    Score: 0.059
  3. Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery. Nano Today. 2021 Feb; 36.
    View in: PubMed
    Score: 0.057
  4. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy. Cell. 2020 11 25; 183(5):1219-1233.e18.
    View in: PubMed
    Score: 0.057
  5. Selective Trafficking of Light Chain-Conjugated Nanoparticles to the Kidney and Renal Cell Carcinoma. Nano Today. 2020 Dec; 35.
    View in: PubMed
    Score: 0.056
  6. Lymph node fibroblastic reticular cells deposit fibrosis-associated collagen following organ transplantation. J Clin Invest. 2020 08 03; 130(8):4182-4194.
    View in: PubMed
    Score: 0.055
  7. Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery. EBioMedicine. 2018 Dec; 38:79-88.
    View in: PubMed
    Score: 0.049
  8. Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival. J Clin Invest. 2018 11 01; 128(11):4770-4786.
    View in: PubMed
    Score: 0.049
  9. Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity. Sci Rep. 2018 02 06; 8(1):2461.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.